Stockreport

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma [Yahoo! Finance]

BeOne Medicines Ltd. - American Depositary Shares  (ONC) 
PDF FDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need SAN CARLOS, Calif., December 18, 2025 BUSINESS WIRE )--BeOne Medicines Lt [Read more]